Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 1615 1712 3783
This examiner grants 46% of resolved cases
John Seungjai Kwon works in Tech Center 3700 and Art Unit 1615. The examiner has 116 resolved cases. The data shows an allowance rate of 45.7 percent, which is moderate. An interview lift of 19.3 percent indicates that interviews provide a significant benefit to the likelihood of allowance. This 19.3 percent lift suggests that engaging with the examiner can help resolve outstanding rejections.
The median days to allowance is 1284, providing a standard timeline for prosecution. With 116 resolved cases, the examiner has a substantial track record. The 45.7 percent allowance rate and 1284 median days to allowance are key metrics for planning. Practitioners should consider the 19.3 percent interview lift as a useful tool for the 116 cases resolved by this examiner.
In Art Unit 1615, the 45.7 percent allowance rate indicates a rigorous approach to examination. The 1284 median days to allowance is a reliable indicator of pendency. The 19.3 percent interview lift offers a tactical advantage for applicants seeking to improve their chances. These figures provide a clear and data-grounded perspective on the prosecution experience with this examiner.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18434662 | LIPOPEPTIDES, NANOPARTICLES AND METHODS OF USE | Non-Final OA | Wisconsin Alumni Research Foundation |
| 17815485 | GRAPHENE BIOSCAFFOLDS AND THEIR USE IN CELLULAR THERAPY | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 18543619 | COSMETIC COMPOSITION WITH IMPROVED SOLVENT SYSTEMS | Final Rejection | L’ORÉAL |
| 18556311 | 3D-PRINTING OF STRONG LIVING SCAFFOLDS | Non-Final OA | Northwestern University |
| 18985612 | COMPOSITIONS CONTAINING BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE AND COLORING AGENT | Non-Final OA | L'OREAL |
| 18851876 | BENTON GEL ACTIVATOR COMPOSITION | Non-Final OA | SHISEIDO COMPANY, LTD. |
| 18508058 | BIOMIMETIC LIPOSOMES AND METHODS OF MAKING AND USING THE SAME | Final Rejection | Worcester Polytechnic Institute |
| 18744029 | Oral Care Compositions | Final Rejection | Colgate-Palmolive Company |
| 18027932 | Method for Pleurodesis and Delivery of Drugs to the Lung and Pleural Space | Final Rejection | University of Cincinnati |
| 18865710 | PROTEIN PARTICLES INCLUDING AN ACTIVE AGENT AND METHODS OF MAKING AND USING THE SAME | Non-Final OA | Cornell University |
| 17907455 | A FLEXIBLE FOIL FOR THE DELIVERY OF THERAPEUTIC CARGOS | Final Rejection | University of Copenhagen |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy